Interleukin-15 (IL-15) exhibits biological activities similar to those of interleukin-2 and enhances the proliferation of CD8+ cytotoxic T cells and natural killer cells, which in turn eliminate tumor cells43–49. The gene discussed is CD8A; the disease is neoplasm.